John M. Dagle

Substrate Specificity and Kinetics of Degradation of Antisense Oligonucleotides by a 3′ Exonuclease in Plasma

Paul S. Eder, Rene J. DeVine, John M. Dagle et al. · Antisense Research and Development · 1991 · 285 citations

Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3.

Jay D. Potts, John M. Dagle, Joseph A. Walder et al. · Proceedings of the National Academy of Sciences · 1991 · 257 citations · Full text

Epithelial-mesenchymal Transformation, Cardiac Progenitor Cells, Tgf Beta +20

Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants

Lindsey Morrow, Brandie D. Wagner, David A. Ingram et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 185 citations · Full text

Outcomes at 18 to 22 Months of Corrected Age for Infants Born at 22 to 25 Weeks of Gestation in a Center Practicing Active Management

Patricia L. Watkins, John M. Dagle, Edward F. Bell et al. · The Journal of Pediatrics · 2019 · 120 citations

Family Medicine, Perinatal Health, Neonatology +13

Targeted degradation of mRNA in<i>Xenopus</i>oocytes and embryos directed by modified oligonucleotides: studies of An2 and cyclin in embryogenesis

John M. Dagle, Joseph A. Walder, Daniel L. Weeks · Nucleic Acids Research · 1990 · 103 citations · Full text